Chi-kuan Chen

TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

High frequency of BRAF mutations and concomitant KRAS mutations in Taiwanese ovarian clear cell carcinoma.

High frequency of BRAF mutations and concomitant KRAS mutations in Taiwanese ovarian clear cell carcinoma.

Journal: Taiwanese journal of obstetrics & gynecology
Published: December 23, 2024

Finger-powered agglutination lab chip with CMOS image sensing for rapid point-of-care diagnosis applications.

Finger-powered agglutination lab chip with CMOS image sensing for rapid point-of-care diagnosis applications.

Journal: Lab on a chip
Published: December 25, 2019

Discovery of T-1101 tosylate as a first-in-class clinical candidate for Hec1/Nek2 inhibition in cancer therapy.

Discovery of T-1101 tosylate as a first-in-class clinical candidate for Hec1/Nek2 inhibition in cancer therapy.

Journal: European journal of medicinal chemistry
Published: October 10, 2019

Clinical Evaluation of IntelliPlex™ KRAS G12/13 Mutation Kit for Detection of KRAS Mutations in Codon 12 and 13: A Novel Multiplex Approach.

Clinical Evaluation of IntelliPlex™ KRAS G12/13 Mutation Kit for Detection of KRAS Mutations in Codon 12 and 13: A Novel Multiplex Approach.

Journal: Molecular diagnosis & therapy
Published: July 27, 2019

The Her2 gene aberrations in mucinous ovarian carcinoma: Analysis of twenty-one cases.

The Her2 gene aberrations in mucinous ovarian carcinoma: Analysis of twenty-one cases.

Journal: Taiwanese journal of obstetrics & gynecology
Published: May 22, 2019

Molecular profiling of c-KIT oncogene in high grade neuroendocrine carcinoma of the uterine cervix: Analysis of twelve cases.

Molecular profiling of c-KIT oncogene in high grade neuroendocrine carcinoma of the uterine cervix: Analysis of twelve cases.

Journal: Taiwanese journal of obstetrics & gynecology
Published: November 25, 2018

CCN2 promotes drug resistance in osteosarcoma by enhancing ABCG2 expression.

CCN2 promotes drug resistance in osteosarcoma by enhancing ABCG2 expression.

Journal: Journal of cellular physiology
Published: June 02, 2018

Leukocyte Cell-Derived Chemotaxin 2 Retards Non-Small Cell Lung Cancer Progression Through Antagonizing MET and EGFR Activities.

Leukocyte Cell-Derived Chemotaxin 2 Retards Non-Small Cell Lung Cancer Progression Through Antagonizing MET and EGFR Activities.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: May 16, 2018

EIF3C-enhanced exosome secretion promotes angiogenesis and tumorigenesis of human hepatocellular carcinoma.

EIF3C-enhanced exosome secretion promotes angiogenesis and tumorigenesis of human hepatocellular carcinoma.

Journal: Oncotarget
Published: October 11, 2017

Expression of 3β-Hydroxysteroid Dehydrogenase Type 1 in Breast Cancer is Associated with Poor Prognosis Independent of Estrogen Receptor Status.

Expression of 3β-Hydroxysteroid Dehydrogenase Type 1 in Breast Cancer is Associated with Poor Prognosis Independent of Estrogen Receptor Status.

Journal: Annals of surgical oncology
Published: March 12, 2017

Corrigendum to "Glutaminase 2 stabilizes Dicer to repress Snail and metastasis in hepatocellular carcinoma cells" [383 (2016) 282-294].

Corrigendum to "Glutaminase 2 stabilizes Dicer to repress Snail and metastasis in hepatocellular carcinoma cells" [383 (2016) 282-294].

Journal: Cancer letters
Published: January 29, 2017

Multipoint Kras oncogene mutations potentially indicate mucinous carcinoma on the entire spectrum of mucinous ovarian neoplasms.

Multipoint Kras oncogene mutations potentially indicate mucinous carcinoma on the entire spectrum of mucinous ovarian neoplasms.

Journal: Oncotarget
Published: September 20, 2016
Showing 1-12 of 37

Last Updated: 09/26/2026